Gulf Pharmaceuticals Julphar saw its first quarter profit plunge on the back of lower sales. Photo by Jeff Topping/The National
Gulf Pharmaceuticals Julphar saw its first quarter profit plunge on the back of lower sales. Photo by Jeff Topping/The National

Business

Julphar Q1 profit plummets 58% on revenue drop

The company reported a 21 per cent decline in sales in the first three months of the year

Mahmoud Kassem

May 17, 2018

Julphar, a Ras Al Khaimah-based pharmaceutical company, reported a 58 per cent drop in first quarter net profit on the back of a drop in revenue.

The company said profit for the period fell to Dh18.4 million from the same period a year earlier. Net sales declined 21 per cent to Dh264m in the first three months of the year from the corresponding period in 2017. The company said the results were calculated according to the new accounting standard IFRS 9 and IRS 15.

The company “delivered a good first quarter performance, in line with our internal target,” said Jerome Carle, general manager of Julphar. “In the first three months of 2018, we made significant progress in the UAE and Levant and we resumed our operation in Libya.”

_______________

Read More:

______________

Mr Carle said that the company, which distributes medicines to over 40 countries, had new product launches in cardiology and respiratory and executed a long-term strategy in consumer healthcare. He also said Julphar is well positioned for a profitable second-quarter and remains focused on delivering shareholder value through organic and strategic growth opportunities.

“In combination with our expansion initiatives in places such as Saudi Arabia and Africa, we believe there are firm drivers for our growth in 2017," he said.

The company also said it plans to launch 25 products in the UAE and register 200 new products in the region. Julphar has thirteen facilities in the UAE and has manufacturing facilities in Ethiopia, Bangladesh and Saudi Arabia.

Profile Box

Company/date started: 2015

Founder/CEO: Mohammed Toraif

Based: Manama, Bahrain

Sector: Sales, Technology, Conservation

Size: (employees/revenue) 4/ 5,000 downloads

Stage: 1 ($100,000)

Investors: Two first-round investors including, 500 Startups, Fawaz Al Gosaibi Holding (Saudi Arabia)

Know your cyber adversaries

Cryptojacking: Compromises a device or network to mine cryptocurrencies without an organisation's knowledge.

Distributed denial-of-service: Floods systems, servers or networks with information, effectively blocking them.

Man-in-the-middle attack: Intercepts two-way communication to obtain information, spy on participants or alter the outcome.

Malware: Installs itself in a network when a user clicks on a compromised link or email attachment.

Phishing: Aims to secure personal information, such as passwords and credit card numbers.

Ransomware: Encrypts user data, denying access and demands a payment to decrypt it.

Spyware: Collects information without the user's knowledge, which is then passed on to bad actors.

Trojans: Create a backdoor into systems, which becomes a point of entry for an attack.

Viruses: Infect applications in a system and replicate themselves as they go, just like their biological counterparts.

Worms: Send copies of themselves to other users or contacts. They don't attack the system, but they overload it.

Zero-day exploit: Exploits a vulnerability in software before a fix is found.

While you're here
The specs
Engine: 3.0-litre twin-turbo flat-six

Power: 480hp at 6,500rpm

Torque: 570Nm from 2,300-5,000rpm

Transmission: 8-speed dual-clutch auto

Fuel consumption: 10.4L/100km

Price: from Dh547,600

On sale: now